Wed, Oct 1, 2014, 7:01 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • swhitemd50 swhitemd50 Dec 1, 2011 5:01 PM Flag

    VRUS shares going lower

    I read somewhere that there is a 3 percent fee if GILD backs out of the deal. So I guess it might cost GILD about 330 million. Of course, not backing out could cost them several billion if PSI-7977 does not live up to the hype.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • The November 21 Reuters article (see Vertex news headlines on Yahoo Finance on 11/21/11) states that a source said there is a "standard break-up fee" of about 3 percent of the total deal value. I agree that is highly unusual to see such a discrepancy between the acquisition price and the current price of VRUS. Maybe GILD is having second thoughts. Maybe they are wondering about why the genotype 1 Hep C patients need to be "interferon intolerant" to benefit from the PSI-7977 miracle drug.

 
VRTX
107.25-5.06(-4.51%)Oct 1 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.